Jane Street Group, LLC Zentalis Pharmaceuticals, Inc. Call Options Transaction History

Jane Street Group, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2022 May 17, 2022	BUY	$41.58 - $80.89 $390,852 - $760,366	9,400 Added 142.42%	16,000 $738,000
Q4 2021 Feb 15, 2022	BUY	$66.92 - $84.79 $441,672 - $559,614	6,600 New	6,600 $555,000
Q3 2021 Nov 16, 2021	SELL	$46.83 - $73.5 $1.55 Million - $2.43 Million	-33,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$37.41 - $62.25 $1.23 Million - $2.05 Million	33,000 New	33,000 $1.76 Million

143

68M

48.5K

89.6K

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $128M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.